As acceptance rates to Ivy League schools continue to plummet, honors colleges and programs are emerging as a popular—and ...

Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced two upcoming ...

Initiation of dosing in our Phase 1b clinical trial represents an important step in the clinical development of GT-02287 and in Gain’s mission to deliver a disease-modifying therapy to people with ...

Americans, Neumann University will welcome author Mark Bulik to discuss his book about the only officially sanctioned IRA ...

OHSU's pioneering research, clinical trials led to better testing, approval for CTX disease Eric Stewart has a rare disease ...

Due to the rapid rise and impact of artificial intelligence (AI) tools such as ChatGPT, ClaudeAI, and DeepSeek over the past several years, the National Academies’ Forum on Neuroscience and Nervous ...

Dr. Carrie Towbes and George Burtness have been selected as the 82nd Persons of the Year for the Santa Barbara area. The two will be honored for their ...

The translational pilot program is championing a community-led approach to end of life care that starts with connection Frenchs Forest, NSW – 20 March ...

Cidara Therapeutics (CDTX) announced two upcoming presentations at the 38th International Conference on Antiviral Research. The conference ...

Breghilyn Cheska Bagalso, on the hunt for her first co-op, applied to a lab at Harvard Medical School. But after her ...

Nicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, today announced that the last ...

If we undermine our preeminence in medical research and innovation, we will never know what ideas are being lost or what might have been. If we cut people and projects for cost “efficiency,” what we ...